Egyptian Drug Authority signs agreement to enhance vocational training in the medical sector
The activities of the fifth edition of the Africa Health ExCon 2026 witnessed a new step aimed at developing the health sector in Egypt. The Egyptian Drug Authority signed a strategic cooperation protocol with GlaxoSmithKline Egypt to enhance the levels of training and professional development for workers in this vital field.
This cooperation comes within the framework of the Egyptian state's keenness to keep pace with the latest global developments in the pharmaceutical industry. The protocol aims to exchange scientific and technical expertise, which contributes to raising the efficiency of human resources and developing their skills in line with international standards for quality and pharmaceutical safety.
Through this partnership, both parties also seek to support innovation in the Egyptian pharmaceutical sector and provide advanced training programs that serve national goals to improve healthcare. This step is part of broader efforts made by the Authority to enhance cooperation with international companies operating in the Egyptian market.
It is noteworthy that the Africa Health ExCon conference is an important regional platform that brings together experts and specialists in the medical field from across the African continent. It is expected that this cooperation will lead to tangible positive results that will reflect on the quality of pharmaceutical services provided to citizens in Egypt during the coming period.